GoodRx Net Losses

Is GoodRx Profitable?

GoodRx
Profitability
No — net loss
Full Year FY2024
▼ Net Loss
-$49M: Net Income FY2024
$795M: Revenue FY2024
~94%: Gross Margin
~7M: Monthly Users
Despite having one of the highest gross margins in tech (~94%), GoodRx has struggled with GAAP profitability due to high stock-based compensation and restructuring charges. On an adjusted EBITDA basis, the company is profitable.
Explore In-Depth AI & Business Strategy →
fourweekmba.com data card

GoodRx is still not profitable, as it reported a net loss of $8.87 million for 2023, compared to $32.83 million in net loss for 2022, and $25.25 million for 2021.

Related to GoodRx

Scroll to Top

Discover more from FourWeekMBA

Subscribe now to keep reading and get access to the full archive.

Continue reading

FourWeekMBA